NUVB
USDNuvation Bio Inc. Class A Common Stock
$1.810-0.390 (-17.727%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$2.200
最高
$2.230
最低
$1.800
交易量
6.43M
公司基本面
市值
615.9M
行業
生物科技
國家
United States
交易統計
平均交易量
4.17M
交易所
NYQ
貨幣
USD
52週範圍
最低 $1.54當前 $1.810最高 $3.97
相關新聞
Analyst Upgrades
Wedbush Maintains Outperform on Nuvation Bio, Maintains $5 Price Target
Wedbush analyst David Nierengarten maintains Nuvation Bio with a Outperform and maintains $5 price target.
查看更多
BusinessWire
U.S. Food and Drug Administration Approves Nuvation Bio's IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer
Approval follows Priority Review and is supported by the robust TRUST clinical program, in which IBTROZI treatment demonstrated high, durable response rates and brain-penetrant efficacy across different lines of
查看更多
Analyst Upgrades
JMP Securities Reiterates Market Outperform on Nuvation Bio, Maintains $6 Price Target
JMP Securities analyst Silvan Tuerkcan reiterates Nuvation Bio with a Market Outperform and maintains $6 price target.
查看更多
